NBIX- Neurocrine Biosciences, Inc.

Name: Neurocrine Biosciences, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Gano Kyle	140.4K	$23.05M	-
Other	Benevich Eric	52.8K	$8.66M	-
Other	Lippoldt Darin	46.8K	$7.68M	-
Other	Cooke Julie	39.6K	$6.51M	-36,937
Other	Onyia Jude	36.8K	$6.05M	-11,000

Activity

Buys and sells only

Transactions

10 filings · page 42

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Apr 12, 2017	Gano Kyle54	Chief Business Development Off	Sell	13,065	$50.42	$658,773.93	-8.2%
Apr 12, 2017	Bozigian Haig P.	Chief Development Officer	Sell	13,065	$50.42	$658,773.93	-4.8%
Feb 7, 2017	Lloyd-Smith Malcolm49	Chief Regulatory Officer	Sell	843	$43.35	$36,544.81	-43.8%
Feb 7, 2017	Benevich Eric62	Chief Commercial Officer	Sell	953	$43.32	$41,287.11	-43.8%
Feb 7, 2017	Lippoldt Darin60	Chief Legal Officer	Sell	953	$43.34	$41,299.57	-43.8%
Feb 6, 2017	Grigoriadis Dimitri E.	Chief Research Officer	Sell	727	$43.13	$31,355.51	-0.6%
Feb 6, 2017	Bozigian Haig P.	Chief Development Officer	Sell	963	$43.14	$41,543.82	-0.8%
Feb 6, 2017	Gano Kyle54	Chief Business Development Off	Sell	727	$43.15	$31,370.05	-1.2%
Feb 6, 2017	Obrien Christopher Flint	Chief Medical Officer	Sell	1,206	$43.17	$52,063.02	-3.2%
Feb 6, 2017	Coughlin Timothy P75	Chief Financial Officer	Sell	963	$43.14	$41,543.82	-0.7%

← PrevPage 42Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC